261O - Cost-effectiveness analysis of additional abiraterone for hormone-sensitive metastatic prostatic cancer treated with androgen deprivation therapy (ADT)
| Autor: | Chiang, C.L., Choi, H., Mui, W.H., So, T.H. |
|---|---|
| Zdroj: | In Annals of Oncology November 2017 28 Supplement 10:x77-x77 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|